DOI QR코드

DOI QR Code

Analysis of Aconitine Contents in Aconiti Radix Lateralis Preparata and Sambutang-P that Contains Aconiti Radix Lateralis Preparata and Single Oral Toxicity Test

포제부자(炮製附子) 및 포제부자(炮製附子) 함유 삼부탕(蔘附湯)의 aconitine 함량 분석과 단회투여 독성시험

  • Bae, Jeong Hu (Department of Korean Internal Medicine, College of Korean Medicine, Dong-Eui University) ;
  • Kim, Gyeong Cheol (Department of Diagnostics, College of Korean Medicine, Dong-Eui University) ;
  • Shin, Soon Shik (Department of Formula Sciences and Research Center of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) ;
  • Hwang, Won Deuk (Department of Korean Internal Medicine, College of Korean Medicine, Dong-Eui University)
  • 배정후 (동의대학교 한의과대학 내과학교실) ;
  • 김경철 (동의대학교 한의과대학 진단학교실) ;
  • 신순식 (동의대학교 한의과대학 방제학교실 및 한방당뇨비만연구소) ;
  • 황원덕 (동의대학교 한의과대학 내과학교실)
  • Received : 2017.01.31
  • Accepted : 2017.02.13
  • Published : 2017.02.28

Abstract

Objectives : The contents of aconitine in aconiti radix lateralis preparata, purified hot water extract of Aconiti Radix lateralis preparata, and purified hot water extract of Sambutang-P that contains Aconiti Radix lateralis preparata was analyzed to compare toxicity. Toxicity of Sambutang-P that contains Aconiti Radix lateralis preparata was assessed with a single oral toxicity test on 6-week-old male and female Sprague-Dawley rats. Methods : 1. The contents of aconitine in Aconiti Radix lateralis preparata, purified hot water extract of Aconiti Radix lateralis preparata, and purified hot water extract of Sambutang-P that contains Aconiti Radix lateralis preparata was analyzed using the purity test according to the "Korean Herbal Pharmacopoeia". 2. 2,000mg/kg was injected for the single oral toxicity test of purified hot water extract of Sambutang-P that contains Aconiti Radix lateralis preparata, and the test was done for a test group (injection) and a control group, each with 5 male and 5 female rats. For 14 days after injection, rats were observed for general symptoms and changes in weight. Afterwards, blood biochemical test, autopsy, and histophathological exam of the liver was conducted. Results : 1. The contents of aconitine was 0.0785% for Aconiti Radix lateralis preparata, 0.1510% for purified hot water extract of Aconiti Radix lateralis preparata, and 0.1248% for purified hot water extract of Sambutang-P that contains Aconiti Radix lateralis preparata. 2. There was no death of either male or female rats in both the control group and the test group (injection of 2,000mg/kg). 3. No unusual symptom was observed in both the control group and the test group (injection of 2,000mg/kg). 4. No significant change in weight was observed for both male and female rats in the test group (2,000mg/kg). 5. The histopathological exam of ALT, AST, ALP, GGT and LDH showed no significant changes for both male and female rats in the test group (2,000mg/kg). 6. According to the autopsy results, no visible abnormality of organs or tissues was found in both the control group and the test group (2,000mg/kg). 7. According to the histopathological exam of the liver, the effect of the injected material was not observed for either male or female rats in the test group (2,000mg/kg). Conclusions : The contents of aconitine in Aconiti Radix lateralis preparata was lower for decoction of Sambutang-P with ginseng radix alba than for decoction of only Aconiti Radix lateralis preparata. This suggests that ginseng radix alba can dilute toxicity of Aconiti Radix lateralis preparata. As for a single oral toxicity test of Sambutang-P that contains Aconiti Radix lateralis preparata, no abnormal reaction was observed even when the injection amount far exceeded a toxic dose or a lethal dose. Thus, it is deemed that using Sambutang-P at a clinically prescribed dose would not lead to hepatoxicity.

Keywords

Acknowledgement

Supported by : Korea Health Industry Development Institute (KHIDI)

References

  1. Xue Min Gao, Gong Sheng Zhong. Science of Chinese Materia Mmedica (Volume 1). 2nd edition. Beijing: People's Medical Publishing House, 2015: 795-796.
  2. The Korean Pharmacopoeia Monographs part II. 11th Edition. Cheongju: MINISTRY OF FOOD AND DRUG SAFETY, 2016: 47-48.
  3. Zu Guang Ye. Toxic Chinese medicine aconite. first edition. first printing. Beijing: China Press of Traditional Chinese Medicine, 2015: 54-65.
  4. Dong Mei Wang, Yan Hong Wang, Yong Ji Li, Rui Wang, Qing Xia Guan. Progress of aconite toxicity, pharmacodynamic material basis and analysis method research. Heilongjiang Medicine Journal. 2011;24(1): 45-47.
  5. Mo Ran Wang. The toxicity of aconite. Shanxi Journal of Traditional Chinese Medicine. 2012;33(7): 908-910.
  6. National Pharmacopoeia Commission. Pharmacopoeia of The People's Republic of China (volume 1). 2015 edition. Beijing: China Medical Science and Technology Publishing House, 2015: 191-193.
  7. Chang Xun Chen, Shan Jun Xu. Progress in the material basis and the role research poisonous licorice, dried ginger and aconite reduced compatibility. Traditional Chinese Drug Research & Clinical Pharmacology 2006;11(17): 472-476.
  8. Bo Hong, Yong Qing Qiu. Theoretical study on the decreased toxicity mechanism of aconitine analogs in aconitum carmichaeli by density functional theory. Journal of Molecular Science 2008;24(3): 216-219.
  9. Kai Xin Liu. Study on the toxicity and safety of aconite. Medicine & people. 2014;27(7): 296.
  10. Sang-Wook Pak, Ja-Won Jang, Jong-Hwan Kim, Wo-Jin Shin, Hyun-Wo Hong, Ji-Yun Kim, In-sun Choi, Won-Duck Hwang. Clinical study about ginseng(人蔘). Aconiti Iateralis Preparata Radix(附子)'s practical usc in the early Stroke of old man patient. The Journal of Korean Oriental Internal Medicine 2003; 24: 42-55.
  11. In-sun Song, Min-seok Oh, Tae-won Song. The study of Acontii Tuber in Bang-Yak-Hap-Pyun. THESIS COLLECTION RESEARCH INSTITUTE OF KOREAN MEDICINE. 2001; 10(1): 323-336.
  12. Hyungho Lee, Sangjong Ryu. The investigation about the Seokgok's use of Rehmanniae RadiX and Aconiti Iateralis Preparata Radix. Journal of Somun Oriental Medical Society 2007; 10(1): 75-82.
  13. Zhejiang Institute of traditional Chinese Medicine, Huzhou Hospital of Traditional Chinese Medicine proofread. Classified Assemblage of Medical Prescriptions(collated and punctuated text, volume 7). first edition. first printing. Beijing: People Health Publishing House, 1982:392.
  14. Ja-won Jang, Su-jin Song, Ji-yun Kim, Sung-soon Min, Ki-tak Kim, Won-duk Hwang. The Consequences of Long-period Dosages of Herbal Medicine Including Boo-ja and Cheon-o on Liver Injury. The Journal of Korean Oriental Internal Medicine 2005; 26(4): 828-835.
  15. Sujin Song, Jawon Jang, Wonduk Hwang. The Consequences of Long-period Dosages of Herbal Medicine Including Boo-ja and Cheon-o on Liver Injury(II). The Journal of Korean Oriental Internal Medicine 2006; 27(2): 407-415.
  16. Hyunyoung Han, Wonduk Hwang. The Study of Dosages of Herbal Medicine Including Aconiti Lateralis Preparata Radix and Aconiti Tuber on Aspartate Aminotransferase, Alanine Aminotransferase. The Korea Journal of Herbology 2009; 24(4): 87-93.
  17. Youngjun Lee, Wonduk Hwang, Jaewook Lee, Huijin Jeong, Suhyun Bae, Kyugon Kim. The Study of Safety of Herbal Medicine Including Fuzi(附子) on High Range of LFT, RFT Patients. The Korean Journal of Oriental Medical Prescription 2011; 19(2): 179-189.
  18. Ahn SY. The Consequences of Dosage of Herbal Medicine Including Buja and Cheono on Electrocardiography. Master's thesis of Dongeui University Graduate School 2015: 1-28.
  19. Hae-ryong Jeong, Byun-woo Son, Gyeong-cheul Kim, Soon-shik Shin, Won-deuk Hwang. Single Oral Dose Toxicity Study and Aconitine Content Analysis of Raw Aconiti Tuber and Sambu-tang. Journal of Internal Korean Medicine 2016;37(3):427-441.
  20. The Korean Herbal Pharmacopoeia. Cheongju: MINISTRY OF FOOD AND DRUG SAFETY, 2016: 362-363.
  21. FDA. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, 2005.
  22. The State Administration of traditional 'Chinese medicine Chinese Materia Medica' editorial board. 'Chinese Materia Medica'(volume 3). first edition. first printing. Shanghai: Shanghai Science and Technology Press, 1999: 110-111.